Versant Capital Management’s Revolution Medicines RVMD Stock Holding History

Versant Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92.5K	Buy	494 +34	+7%	+$4.97K	0.01%	979
2026 Q1	$44.7K	Buy	460 +314	+215%	+$31.7K	﹤0.01%	1300
2025 Q4	$11.6K	Hold	146	–	–	﹤0.01%	1930
2025 Q3	$6.82K	Sell	146 -81	-36%	-$3.17K	﹤0.01%	2089
2025 Q2	$8.35K	Buy	227 +205	+932%	+$7.88K	﹤0.01%	1968
2025 Q1	$778	Buy	22 +13	+144%	+$528	﹤0.01%	2385
2024 Q4	$394	Buy	+9	New	+$454	﹤0.01%	2292
2023 Q4	–	Sell	-20	Closed	-$554	–	1997
2023 Q3	$554	Hold	20	–	–	﹤0.01%	1671
2023 Q2	$535	Buy	+20	New	+$491	﹤0.01%	1819

Other funds holding RVMD

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

WPC

Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

SCA

Sandy Cove Advisors Hingham, Massachusetts $400M AUM 27.68% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

CPM

Connective Portfolio Management New York $60.1M AUM 88.93% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Versant Capital Management's RVMD Position: Q2 2026 in Review

Versant Capital Management increased its Revolution Medicines (RVMD) stake by 7.4% in Q2 2026, buying an estimated $4.97K and bringing the position to 494 shares worth $92.5K. The position accounts for 0.01% of the portfolio, ranked #979.

Versant Capital Management first reported a position in RVMD in Q2 2023 and has held it in 9 quarters since. 72 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Versant Capital Management held 494 shares of Revolution Medicines worth $92.5K as of Q2 2026.
Versant Capital Management bought 34 Revolution Medicines shares in Q2 2026, an estimated $4.97K.
Revolution Medicines made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #979 holding.
Versant Capital Management first reported a position in Revolution Medicines in Q2 2023 and has held it in 9 quarters since.
72 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.